ロード中...
MET Exon 14 Alterations in Lung Cancer: Exon Skipping Extends Half-Life
MET exon 14 alterations are a diverse group of mutations, many of which disrupt splice acceptor or donor sites leading to exon 14 skipping, impaired receptor degradation, and oncogenic transformation. These alterations are clinically targetable with MET-directed therapy.
保存先:
| 出版年: | Clin Cancer Res |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4911276/ https://ncbi.nlm.nih.gov/pubmed/27009743 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-16-0229 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|